Knee Discomfort Clinical Trial
— HIPEr-KneeOfficial title:
High-load Resistance Training Compared With Usual Care for Treatment of Painful Knee Joint Hypermobility in Young Adults: A Randomised Controlled Trial (the HIPEr-Knee Study)
Pain associated with knee joint hypermobility is common in the adult population, but evidence on treatment is sparse. This study investigates if high-load resistance training is superior to usual care in improving activity-related pain in young patients (18-45 years) with hypermobile joints and knee pain.
Status | Recruiting |
Enrollment | 90 |
Est. completion date | June 1, 2026 |
Est. primary completion date | June 1, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 45 Years |
Eligibility | Inclusion criteria - Persistent knee pain for = 3 months (self-reported) - Knee pain = 30mm during the last week using a 0-100 mm visual analogue scale (VAS; 0=no pain and 100=worst imaginable pain) (self-reported) - Generalised joint hypermobility assessed with the Five-Part Hypermobility Questionnaire (positive = 2/5) (self-reported) - Local knee joint hypermobility using the passive hyperextension of the knee in standing (positive > 10 degrees of hyperextension) and confirmed in supine lying (heel resting on 20 cm high block on the bench surface), with passive knee hyperextension (positive > 10 degrees) (objectively measured) Exclusion criteria - Diagnosed with patellar tendinopathy - Pregnancy or childbirth within the past year (due to increased levels of relaxin that could affect joint stability) - Knee surgery within the past year - Participation in regular structured resistance training within the past six months - Inability to speak and understand Danish. - All types of Ehlers-Danlos syndrome - Other heritable connective tissue disorders such as Marfan syndrome, osteogenesis imperfecta, Loeys-Dietz syndrome, Stickler syndrome, skeletal dysplasias - Autoimmune rheumatic connective tissue disorders such as lupus, rheumatoid arthritis; Chromosomal conditions such as Fragile X syndrome, Kabuki syndrome, Down syndrome - Neuromuscular disorders that can cause joints to become unstable, such as multiple sclerosis |
Country | Name | City | State |
---|---|---|---|
Denmark | Physiotherapy Clinics Region of Southern Denmark | Odense | Fyn |
Denmark | University of Southern Denmark | Odense | Fyn |
Lead Sponsor | Collaborator |
---|---|
University of Southern Denmark | Independent Research Fund Denmark, Odense Patient Data Explorative Network |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Knee pain past week | Knee pain for the past week is measured using the Visual Analogue Scale (0-100, 100 = worse) | Baseline, 6 weeks, 12 weeks, 12 months | |
Other | Tampa scale of Kinesiophobia (TSK) 11 item | Tampa scale of Kinesiophobia is used to measure impression of change in fear of movement from baseline to 16 weeks follow-up. It consists of an 11-item scale where each question is scored on a 4 point Likert scale, with 1 indicating, "strongly disagree" and 4 indicating, "strongly agree". The total scores range from 11-44, with higher scores representing increased fear of movement. | Baseline, 12 weeks, 12 months | |
Other | EQ-5D-5L | the European Quality of life-5 Dimensions-5-Level measures change in health related quality of life and includes the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS).
The EQ-5D descriptive system comprises five dimensions (mobility, Self-care, usual activities, pain/discomfort and anxiety/depression). Each dimension is rated using a five-level ordinal scale from no problems to extreme problems. It results in a preference based index that range from states worse than death (<0), to 1 (full health), anchoring dead at 0. A score of one indicates that the participants perceived their health at the best possible state and a score below null that the participants perceived their health worse than death. |
Baseline, 12 weeks, 12 months | |
Other | EQ VAS | the European Quality of life-5 Dimensions-5-Level measures change in health related quality of life and includes the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS).
The EQ VAS measures change in health related quality of life. It includes a visual analogue scale where own health 'today´ is rated on a scale from 0 (worst imaginable health) to 100 (best imaginable health). |
Baseline, 12 weeks, 12 months | |
Other | Global perceived effect (GPE) | To measure the patients self-rated impression of improvement at follow-up the GPE will be used related to knee problems. GPE measures self-rated impression of improvement since baseline assessment on a 7-point scale (1 "worse, an important worsening" to 7 "better, an important improvement) | 12 weeks, 12 months | |
Other | PASS | Patient Acceptable Symptom State "When you think of your shoulder function, will you consider your current condition as satisfying? By shoulder function, you should take into account your activities of daily living, sport and recreational activities, your pain and other symptoms and your quality of life". Answered by "yes" or "no". | 12 weeks, 12 months | |
Other | TF | Treatment Failure Only answered by patients answering "no" to PASS. "Would you consider your current state as being so unsatisfactory that you consider the treatment to have failed?". Answered by "yes" or "no". | 12 weeks, 12 months | |
Other | Clinical important difference | American College of Rheumatology response criteria 20% and 50% | 12 weeks, 12 months | |
Other | Knee instability questions | Within the last month, have you experienced that your knee was unstable or about to give out? To what extent has the experience of your knee feeling unstable or giving out affected your daily activity level within the last month? | Baseline, 12 weeks, 12 months | |
Other | Tendon stiffness | Stiffness of the patellar tendon is assessed based on corresponding values of tendon force and tendon deformation (measured by use of B-mode ultrasonography). Subgroup of patients (n = 30) | Baseline, 12 weeks | |
Other | Quadriceps rate of torque development (RTD) | Rate of torque development in the quadriceps muscle. Subgroup of patients (n = 30) | Baseline, 12 weeks | |
Other | Patella instability | Moving patellar apprehension test will be used to assess patella instability. Subgroup of patients (n = 30) | Baseline, 12 weeks | |
Other | Quadriceps maximal voluntary isometric contraction | Isometric maximal voluntary contraction in the quadriceps muscle. Subgroup of patients (n = 30) | Baseline, 12 weeks | |
Primary | Visual Analogue Scale Nominated Activity | The primary outcome is the Self-reported knee pain during an activity nominated by patients to be the most aggravating for their present knee pain (VAS nominated activity - VASNA, 0-100, 100 = worse).
The primary endpoint is at 12-week follow-up. |
Baseline, 6 weeks, 12 weeks (primary endpoint), 12 months | |
Secondary | Knee injury and Osteoarthritis Outcome Score (KOOS) | Knee injury and Osteoarthritis Outcome Score is a validated knee-specific questionnaire used to assess patient-reported outcomes in the continuum from knee injury to osteoarthritis and is widely used for different types of knee pathology. (0-100, 100 = best) | Baseline, 12 weeks, 12 months | |
Secondary | Adverse events | Adverse events will be defined as any unintended, negative findings, symptom, or illnesses that occur during the study assessments or interventions, whether attributable to the project or not. | Up to 12 months | |
Secondary | Dynamic knee strength | Dynamic leg strength will be established by a 5-repetition maximum leg press (single leg) by a standardised protocol. | Baseline, 12 weeks | |
Secondary | Knee reposition sense | Sitting active knee joint reposition (proprioception) test will be performed using a HALO Digital Goniometer, to assess mean absolute angle error (AAE) | Baseline, 12 weeks | |
Secondary | Single-Leg-Hop for Distance | The patients will be instructed to hop forward as far as possible and land steadily and stand still for at least three seconds. | Baseline, 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04506411 -
Turmeric Efficacy for Mobility and Joint Function
|
N/A | |
Recruiting |
NCT04752761 -
Compliance With PROMs Detection Through Digital Support and Correlation Compared Standard to Outpatient Detection in Knee Prosthetics
|
N/A | |
Completed |
NCT05975879 -
A Study of the Feasibility of Using the Dietary Supplement "ARTNEO" in Patients With Osteoathritis
|
N/A | |
Not yet recruiting |
NCT05824676 -
DePuy Synthes Variable Angle LCP Patella Plating System Study
|
N/A | |
Completed |
NCT03072108 -
Dietary Supplement for Joint: the OLE Study
|
N/A | |
Completed |
NCT02157701 -
Polyherbal Capsule Formulation for Joint Health
|
Phase 4 | |
Completed |
NCT04420091 -
Hydrolyzed Fish Cartilage Effect on Knee Joint Functionality and Discomfort in Adult Population
|
N/A | |
Completed |
NCT03041077 -
Influence of Instaflex Advanced Supplement on Joint Function
|
N/A | |
Recruiting |
NCT05060536 -
Infrapatellar Fat Pad Excision in Total Knee Arthroplasty
|
N/A | |
Completed |
NCT05347602 -
Gold Factor on Knee Joint Health and Function
|
N/A | |
Recruiting |
NCT04537013 -
Clinical Study of Chondro-Gide® for Large Chondral Lesions in the Knee
|
N/A | |
Not yet recruiting |
NCT05822401 -
Prevention, Management and Rehabilitation of Knee Osteoarthritis at the Workplace
|
N/A |